Doctor profile · Federal record
Dr. Melanie Rohr, MD
Rheumatology Physician (CMS: Rheumatology) · Wichita, KS
- NPI 1710276415
- Accepts Medicare
- MIPS 75.4 / 100 · 2023
- 15 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1921 N Webb RD
Wichita, KS 672063405
(316) 612-4815
fax (316) 612-4825
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- November 24, 2020
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Kansas #04-38670
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710276415. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
125,807
Distinct HCPCS
10
Medicare allowed
$1,572,514
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 70,000 | 19 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 21,950 | 28 | $13 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 13,020 | 14 | $10 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,025 | 23 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 6,120 | 62 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 469 | 251 | $120 | |
80053 |
Blood test, comprehensive group of blood chemicals | 421 | 225 | $10 | |
36415 |
Insertion of needle into vein for collection of blood sample | 420 | 251 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 402 | 209 | $8 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 369 | 77 | $59 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 2,444. This provider delivers 51× the peer median.Open Payments
Industry payments received
All-time total
$993
Transactions
53
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 20 | $344.10 | |
| PFIZER INC. | 14 | $193.76 | |
| Alexion Pharmaceuticals, Inc. | 2 | $148.78 | |
| GlaxoSmithKline, LLC. | 6 | $105.89 | |
| Amgen Inc. | 4 | $82.02 | |
| HOSPIRA, INC. | 2 | $33.42 | |
| Novartis Pharmaceuticals Corporation | 2 | $27.67 | |
| Kyowa Kirin, Inc. | 1 | $23.33 | |
| Mallinckrodt Hospital Products Inc. | 1 | $18.53 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.82 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,076
Patients
703
Total drug cost
$1,201,876
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 663 | 142 | $31,028 |
| Gabapentin | Generic | 419 | 83 | $6,971 |
| Methotrexate (Methotrexate Sodium) | Brand | 360 | 88 | $8,853 |
| Pregabalin | Generic | 278 | 45 | $12,362 |
| Prednisone | Generic | 246 | 102 | $1,254 |
| Duloxetine Hcl | Generic | 237 | 47 | $4,991 |
| Leflunomide | Generic | 147 | 37 | $5,561 |
| Allopurinol | Generic | 116 | 28 | $1,692 |
| Meloxicam | Generic | 112 | 35 | $652 |
| Celecoxib | Generic | 110 | 21 | $5,919 |
Hospital affiliations
Frequently asked questions
What is Dr. Melanie Rohr's medical specialty?
Dr. Melanie Rohr practices Rheumatology Physician in Wichita, KS.
Where does Dr. Melanie Rohr practice?
Dr. Melanie Rohr practices at 1921 N Webb RD, Wichita, KS 672063405. Office phone: 3166124815.
What is Dr. Melanie Rohr's NPI?
Dr. Melanie Rohr's National Provider Identifier (NPI) is 1710276415, issued by NPPES.
Does Dr. Melanie Rohr accept Medicare assignment?
Yes. Dr. Melanie Rohr accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melanie Rohr commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.